September 2015 Vol 8, No 6

This cardiometabolic health theme issue of American Health & Drug Benefits highlights diabetes as a major contributor to cardiometabolic disease, with enormous clinical and economic burden.
As the healthcare delivery system shifts its focus from “volume” to “value,” it must also change the way executives and physician leaders are paid.
Diabetic retinopathy (ie, damage to the small blood vessels in the retina) is one of the most common complications in patients with chronic diabetes.
The Economics of Screening Patients with Diabetes for Diabetic Retinopathy
Evaluating the Benefits and Cost of the Sodium-Glucose Cotransporter 2 Inhibitors
Approximately 870,000 new cases of heart failure occur annually. Heart failure is projected to affect more than 8 million individuals aged ≥18 years in the United States by 2030, representing a 46% increase from 2012.

Results 1 - 6 of 6
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME